The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis

The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis

AbstractBackground Despite the widespread use of classical cholesterol-lowering drugs to mitigate the adverse impacts of dyslipidaemia on atherosclerosis, many patients still face a substantial residual risk of developing atherosclerotic cardiovascular disease (CVD). This risk is partially attribute...

Full description

Bibliographic Details
Main Authors: Panagiotis Stachteas, Paschalis Karakasis, Dimitrios Patoulias, Francesco Clemenza, Nikolaos Fragakis, Manfredi Rizzo
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
SGLT-2 inhibitors
FMD
PWV
IMT
arterial stiffness
endothelial dysfunction
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2024.2304667

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2024.2304667

Similar Items